Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
JUNS · NASDAQ · Pharmaceutical Preparations
$1.46−0.06 (−3.95%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day
Jupiter Neurosciences (JUNS) · oqro.io/stocks/JUNS · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Jul 1, 2025 · Filed Jul 4, 2025
Director purchased ~$257 of JUNS shares in the open marketSourceInsider trade · Traded Jul 1, 2025 · Filed Jul 4, 2025
Director purchased ~$259 of JUNS shares in the open marketSourceInsider trade · Traded Jul 1, 2025 · Filed Jul 4, 2025
Director purchased ~$257 of JUNS shares in the open marketSourceInsider trade · Traded Jul 1, 2025 · Filed Jul 3, 2025
CEO purchased ~$505 of JUNS shares in the open marketSourceInsider trade · Traded Jul 1, 2025 · Filed Jul 3, 2025
CEO purchased ~$3.2K of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
CEO purchased ~$1.6K of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
CEO purchased ~$1.1K of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
CEO purchased ~$721 of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
CEO purchased ~$980 of JUNS shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jul 1, 2025
CEO purchased ~$176 of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
CEO purchased ~$1.5K of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
CEO purchased ~$2K of JUNS shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jul 1, 2025
Director purchased ~$261 of JUNS shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jul 1, 2025
Director purchased ~$250 of JUNS shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jul 1, 2025
Director purchased ~$263 of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
Director purchased ~$259 of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
Director purchased ~$258 of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
Director purchased ~$105 of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
Director purchased ~$102 of JUNS shares in the open marketSourceInsider trade · Traded Jun 27, 2025 · Filed Jul 1, 2025
Director purchased ~$104 of JUNS shares in the open marketSourceInsider trade · Traded Jun 30, 2025 · Filed Jul 1, 2025
Director purchased ~$255 of JUNS shares in the open marketSource